from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3212/-

LFCtreatmentdescriptionclass of inhibitor

-1.959

Amikacinug/mL Amikacintranslation

-1.663

Cap5-10ug/mL Capreomycintranslation

-1.579

Rox10-50 ug/mL Roxithromycintranslation

0.444

SM2-5 ug/mL Streptomycintranslation

-2.282

Tet5-10 ug/mL Tetracyclinetranslation

-1.002

Rif0.2-5ug/mL Rifampicintranscription

-0.414

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.233

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-2.119

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.626

CPZ10-50 ug/mL Chlorpromazinerespiration

1.154

Clofazimine10-13 ug/mL Clofaziminerespiration

0.034

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.086

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-2.133

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.257

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.086

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.639

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.706

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.251

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.073

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

2.199

KCN5-20 ug/mL Potassium cyaniderespiration

1.061

NaN30.2-2 mM Sodium aziderespiration

-0.383

Nigericin50 uM Nigericinrespiration

-0.801

TRC10-150 ug/mL Triclosanrespiration

-0.528

TRZ10-25 ug/mL Thioridazinerespiration

1.331

Valinomycin0.5-10 uM Valinomycinrespiration

-0.259

ZnSO42 mM ZnSO4respiration

-0.571

menadione6-10 ug/mL Menadionerespiration

0.579

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.049

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.010

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.159

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.043

NRP_1Non-replicating persistence stage 1dosRassociated

0.580

Amp0.2mg/mL AmpicillincellWall

0.073

Cephalexin20-100 ug/mL CephalexincellWall

-0.359

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.248

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.313

EMB10-20 ug/mL EthambutolcellWall

-0.187

Eta12-40 ug/mL EthionamidecellWall

0.111

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.254

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.361

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.113

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.189

BZA0.12 mg/mL BenzamidearomaticAmides

0.000

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.086

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.372

H2O24 mM hydrogen peroxideDNAdamaging

-0.218

Levo10 ug/mL LevofloxacinDNAdamaging

-0.127

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.237

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.848

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.134

UVUV-irradiationDNAdamaging

-0.416

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.417

Antimycin12.5-50 ug/mL Antimycin A?

-0.120

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.001

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.024

PA_2110-50 ug/mL Antitubercular compound PA-21?

2.184

PA8240.2-2 ug/mL PA-824?

2.474

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.899

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.129

Verapamil50 uM Verapamil?

-0.026

mercaptoethanol2 mM 2-Mercaptoethanol?

0.253

methoxatin10-20 ug/mL Methoxatin?